Search Results for "Blue Oval Pill With 68 Taro"

15:12 EDT 3rd September 2015 | BioPortfolio

Matching Channels

Blue hues

Von Willebrand's Disease

von Willebrand disease (vWD) is the most common hereditary coagulation abnormality described in humans, although it can also be acquired as a result of other medical conditions. It arises from a qua...

Matching News

Taro to Announce First Quarter Results on August 6, 2015

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it plans to release its financial results for the quarter and three months ended June 30, 2015, after the clos...

From blue pill to blue light

(ETH Zurich) Taking men's concerns seriously: ETH biotechnologists are developing a biotech solution for erectile dysfunction that consists of a gene construct and a blue light.

FDA approves Taro’s Keveyis for hyperkalemic paralysis

The US Food and Drug Administration has approved Taro Pharmaceutical Industries’ Keveyis (dichlorphenamide)…

Taro to Announce Results for Year Ended March 31, 2015 on May 26, 2015

Earnings Call to Discuss Results to be Conducted Thursday, May 28 at 8:00 am ET Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to releas...

Taro’s Keveyis gets FDA approval

David SalazarIn order to ensure that patients receive treatment for periodic paralysis, Taro will be partnering with Diplomat Pharmacy, where patients and caregivers will receive treatment access and ...

FDA Approves Keveyis (dichlorphenamide) for Primary Hyperkalemic and Hypokalemic Periodic Paralysis

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Aug. 10, 2015-- Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that the U.S. Food and Drug Administration (FDA) has approved Keveyis (dichlorphenamid...

E-pill Medication Reminders launches kitchen fixture pill dispenser

Michael JohnsenE-pill Medication Reminders on Wednesday launched a pill dispenser that can be mounted under a kitchen cabinet.  read more

How Cigna Deal Limits Anthem's Blue Cross Brand

When health plans operate using the Blue Cross and Blue Shield brand, they are generally limited to business in a specific state or region as part of a licensing agreement with their trade group, the ...

Matching PubMed Articles

Red pill, blue pill: reflections on the emerging large vessel stroke 'market'.

Facilitators of Adherence to the Study Pill in the FEM-PrEP Clinical Trial.

FEM-PrEP did not demonstrate a reduction in HIV acquisition because of low study pill adherence. Yet, plasma and intracellular drug concentrations indicated that some participants had evidence of rece...

Cost-Benefit Analysis of Managing the Papuana uninodis (Coleoptera: Scarabaeidae) Taro Beetle in Fiji.

Taro (Colocasia esculenta (L.) Schott) plays a prominent role in the economies and cultures of Pacific Island countries such as Fiji. Unfortunately, taro is highly susceptible to invasion from taro be...

Characterization by Small RNA Sequencing of Taro Bacilliform CH Virus (TaBCHV), a Novel Badnavirus.

RNA silencing is an antiviral immunity that regulates gene expression through the production of small RNAs (sRNAs). In this study, deep sequencing of small RNAs was used to identify viruses infecting ...

Simiao pill ameliorates renal glomerular injury via increasing Sirt1 expression and suppressing NF-κB/NLRP3 inflammasome activation in High fructose-fed rats.

Simiao pill is one of the most frequently prescriptions in traditional Chinese medicine to treat hyperuricemia and gout. This study was to investigate the protective effects of Simiao pill on renal gl...

Search Whole site using Google


Advertisement Advertisement